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 Discs large homolog 5 (Dlg5) is a member of the membrane-associated guanylate 
kinase adaptor family of proteins and is involved in epithelial-to-mesenchymal 
transition via transforming growth factor- (TGF-) signaling. However, the 
mechanism underlying the regulation of TGF- signaling is unclear. We show here that 
Dlg5 interacts and colocalizes with both TGF- type I (TRI) and type II (TRII) 
receptors at plasma membrane. TRI activation is not required for this interaction. 
Furthermore, the overexpression of Dlg5 enhances the degradation of TRI. Proteasome 
inhibitors inhibited this enhanced degradation. These results suggest that Dlg5 interacts 





Discs large homolog 5 (Dlg5) is a member of the membrane-associated guanylate 
kinase (MAGUK) adaptor family of proteins. Each MAGUK family member has at 
least one PDZ (PSD-95, Dlg, ZO-1) domain, an SH3 (Src homology 3) domain, and a 
guanylate kinase domain. Dlg5 was initially proposed to be one of five human 
homologs of the Drosophila Discs large (Dlg) protein, a tumor suppressor gene which is 
required for tumor suppression in imaginal discs, based on similarities in their 
sequences and domain structures [1,2]. However, Dlg5 has its own ortholog in other 
animals including Drosophila, thus it does not belong to the DLG MAGUK subfamily 
but seems to have its own function [2].We have identified Dlg5 as a binding protein for 
vinexin [3,4] and shown that Dlg5 associates with -catenin and that it localizes at 
cell-cell adhesion sites. Several other Dlg5 binding proteins, including p55 [1], syntaxin 
4 [5] and citron kinase [6], have been identified. It has been reported that Dlg5 
polymorphisms are associated with Crohn’s disease (CD), which is an inflammatory 
bowel disease (IBD) [7-11]. Dlg5 knockout mice showed defects in the kidney and 
brain [5] as well as abnormal cell polarity. However, these phenotypes cannot explain 
the pathogenesis of CD.  
Recently, we showed that Dlg5 suppresses the epithelial-to -mesenchymal transition 
(EMT) of renal epithelial cells via the inhibition of TGF- receptor-dependent signaling 
[12]. TGF- stimulation induces intracellular signals via two serine-threonine kinase 
receptors, type I (TRI) and type II (TRII) TGF- receptors. Both TRI and TRII 
form stable homodimers in the absence of TGF-β. Upon TGF- binding, TRI 
homodimers and TRII homodimers form a heterotetrameric receptor complex, leading 
to the activation of two downstream signaling pathways [13-15]. The first pathway is 
Smad signal, in which TGF- stimulation results in TRI-mediated phosphorylation of 
receptor-regulated Smads (Smad2 and Smad3). Phosphorylated Smad2 and Smad3 bind 
to the common mediator Smad (Smad4). The Smad2/3/4 complexes then accumulate in 
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the nucleus and regulate target gene transcription. The other pathway is non-Smad 
signal. TRI activates c-Jun N-terminal kinases (JNK) and p38 mitogen-activated 
protein kinases (p38 MAPK) through MKK4 and MKK3/6, respectively, independent of 
Smad signals. Dlg5 depletion in LLc-PK1 renal proximal tubule epithelial cells 
increases the activation of JNK and p38 MAPK, which are necessary to induce the EMT 
of these cells [12]. Dlg5 seems to affect TR because specific inhibition of TRI or 
overexpression of Smad7, a physiological inhibitor of TR-dependent signaling, 
suppresses Dlg5 depletion-induced EMT. However, the mechanism by which Dlg5 
regulates TR is unknown. Here, we show that Dlg5 interacts with TRI and enhances 
its degradation. 
 
2. Materials and methods 
2.1 Antibodies and reagents 
MG132 and N-Acetyl-L-leucyl-L-leucyl-L-norleucinal (ALLN) were purchased 
from Calbiochem. Bafilomycin and cycloheximide were from WAKO Pure Chemical 
Industries, Osaka, Japan and Sigma, respectively. The following antibodies were used in 
this study: anti-Flag (Sigma), anti-GFP (WAKO Pure Chemical Industries), anti-GFP 
(Santa Cruz Biotechnology), anti-TRI (Santa Cruz Biotechnology), anti--tubulin 
(Sigma), and anti-vinculin (Sigma) antibodies. The anti-Dlg5 antibody was described 
previously [3] . 
 
 
2.2 Cell culture, plasmids, and transfection 
The 293T and Caco-2 cells (RIKEN BRC through the National Bio-Resource 
Project of the MEXT, Japan) were maintained in Dulbecco's Modified Eagle Medium 
containing 10% fetal bovine serum. PC3 cells (obtained from Dr. Yoshiyuki Kakehi of 
Kagawa University) were maintained in RPMI-1640 medium containing 10% fetal 
bovine serum. The longest variant of Dlg5 (Dlg5, see Fig. 1E), which includes 1,919 
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amino acids containing CARD (caspase recruitment domain), coiled-coil, SH3, and 
GUK domains, as well as four PDZ domains, was purchased from Promega (Madison, 
USA). A shorter variant (Dlg5), which lacks the CARD domain, was described 
previously [3]. Dlg5ΔCC, which lacks the CARD and coiled-coil domains and 
corresponds to an open reading frame of KIAA0583 (AB011155), was obtained from 
the Kazusa DNA Research Institute. Plasmids encoding the TGF- receptors 
(TRI-FLAG and TRII-HA, both of which are epitope-tagged at C-terminus) were 
gifts from Dr. S. Aota (RIKEN, Japan). Transfection of plasmid DNA was performed 
using Lipofectamine LTX (Invitrogen) according to the manufacturer’s instructions. 
 
2.3 RNA interference (RNAi)  
The stealth siRNAs for Dlg5/lp-dlg (GGAUUCCAUGGAGUGGGAAACGGAA) were 
designed based on the sequence of the human Dlg5 cDNA (NP_004738) and 
synthesized by Invitrogen. The transfection of siRNAs (10 nM) was performed using 
Lipofectamine RNAiMAX (Invitrogen) as previously described [16]. 
 
2.4 Immunoprecipitation and immunoblotting 
Immunoprecipitation and immunoblotting were performed as previously described 
[12,17]. Briefly, cells cultured under various conditions were washed with PBS. The 
cells were then lysed in RIPA buffer without SDS (150 mM NaCl, 1% NP-40, 0.5% 
sodium deoxycholate, 50 mM Tris-HCl pH 7.5, 0.1 mg/mL p-amidinophenyl 
methanesulfonyl fluoride, 5 g/mL leupeptin, and 10 g/mL aprotinin) on ice for 30 
minutes. Lysates were centrifuged at 18,700 × g for ten minutes. For 
immunoprecipitation, equal amounts of cell lysate were incubated with the indicated 
antibodies for 1 hour and then with Protein G sepharose beads for 1 hour. For 
immunoblotting, cell lysates or immunoprecipitates were electrophoresed and 
transferred onto PVDF membranes (Millipore). After blocking with BLOCKING ONE 
(Nacalai Tesque, Kyoto, Japan), the membranes were incubated with primary antibodies 
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and then with the appropriate secondary antibodies. Antigen detection was performed 
with an LAS 3000 image analyzer (FUJIFILM, Tokyo, Japan) using the ImmunoStar 
LD kit (Wako, Osaka, Japan). Quantification was performed by Multi Gauge 
(FUJIFILM, Tokyo, Japan). 
 
2.5 Immunostaining 
Caco-2 cells were transfected with plasmids encoding GFP-Dlg5ΔCC, TRI-Flag 
and TRII-HA. The cells were cultured on coverslips coated with type IV collagen for 
24 hours. Cells were fixed with methanol for 20 minutes at -20
o
C and blocked with 10% 
goat serum in PBS+ for 30 minutes. They were then incubated with anti-Flag antibody 
and anti-HA antibody for 1 hour at room temperature, followed by incubation with 
Alexa 633-labeled goat anti-rabbit IgG (Invitrogen) and Alexa 546-labeled goat anti-rat 
IgG for 1 hour. Fluorescence imaging was performed with a LSM700 confocal 
microscopy system (Carl Zeiss Co., Ltd.). 
 
2.6 Statistical analysis 
The statistical analysis was performed using Student’s paired t-test. 
 
3. Results 
3.1 Dlg5 interacts with TRI and TRII 
Previously, we showed that Dlg5 suppresses EMT through the inhibition of TGF- 
receptor-mediated signaling [12]. Several molecules, including Smad7 and Smurf1/2, 
attenuate TGF- signaling via binding to the TRs [18]. To examine whether Dlg5 can 
interact with TRs, TRI-Flag and TRII-HA were cotransfected with GFP-tagged 
Dlg5 variant (GFP-Dlg5ΔCC) into 293T cells, followed by coimmunoprecipitation 
using an anti-GFP antibody. As shown in Fig. 1A, both TRI and TRII were 
coprecipitated with Dlg5ΔCC. To check whether Dlg5 could bind TRI independent of 
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TRII and vice versa, we performed immunoprecipitation assays. GFP-Dlg5ΔCC was 
transfected into 293T cells with TRI-Flag and then immunoprecipitated with anti-GFP 
antibody. TRI (Fig. 1B) was coprecipitated with Dlg5ΔCC. The reciprocal 
coimmunoprecipitation experiment confirmed this interaction (data not shown). We also 
examined whether the interaction of Dlg5 with TRII depends on TRI. GFP-Dlg5ΔCC 
was transfected into 293T cells with TRII-HA and then immunoprecipitated with 
anti-GFP antibody. TRII (Fig. 1C) was coprecipitated with Dlg5ΔCC. These results 
indicate that Dlg5 can interact with both TRI and TRII independently. Dlg5 has 
splice variants, such as Dlg5 and  (Fig. 1E, also see Materials and Methods). To 
determine which Dlg5 splice variants can interact with the TRs, 
coimmunoprecipitation experiments with Dlg5, -, and -ΔCC were performed. TRI 
coprecipitated with all these Dlg5 variants (Fig. 1D), suggesting that these variants all 
contain the TRI interaction region. Because TRI coprecipitated the most effectively 
with Dlg5ΔCC, possibly because Dlg5 and Dlg5 were less soluble in the lysis buffer 
than Dlg5ΔCC (Fig. 1D), primarily Dlg5ΔCC was used in subsequent experiments. 
To confirm the interaction between endogenous Dlg5 and the TRs, we performed 
coimmunoprecipitation experiments using PC3 prostate cancer cells in which Dlg5 is 
expressed at high levels. The PC3 cell lysates were subject to immunoprecipitation 
with anti-TRI antibody and examined for coimmunoprecipitation of endogenous Dlg5. 
As shown in Fig. 2, Dlg5 was detected when anti-TRI antibody, but not control IgG, 
was used for the immunoprecipitation. Transfection of Dlg5 siRNA reduced the 
expression of Dlg5 in lysates as well as in the coprecipitation of Dlg5 with TRI. We 
could not detect coimmunoprecipitation of endogenous TRII with Dlg5 because it 
could not be immunoprecipitated efficiently (data not shown). These results suggest 





3.2 TRI activation and kinase activity are not necessary for Dlg5 binding  
The interactions of TRI with Smad7, SARA (Smad anchor for receptor activation), 
and TAK1 (TGF- activated kinase 1) are regulated by TRI activation [18-21]. To 
investigate whether TRI activation affects its interaction with Dlg5, 
coimmunoprecipitation experiments using constitutively active (CA-TRI T204D) and 
kinase-dead (KD-TRI D351A) TRI mutants were performed. As shown in Fig. 3A, 
CA-TRI and KD-TRI were coimmunoprecipitated with Dlg5 similarly to WT-TRI. 
Next, we examined the effect of TGF- stimulation on the Dlg5-TRI interaction. 
After cotransfection of TRI with GFP-Dlg5ΔCC, the cells were incubated with 
TGF- for 30 or 180 minutes before immunoprecipitation was performed (Fig. 3B). 
TRI was coimmunoprecipitated with GFP-Dlg5ΔCC before TGF- stimulation. 
Thirty minutes after TGF- stimulation, phosphorylated Smad2 was detected, thus 
indicating the activation of TRI. However, the amount of TRI coimmunoprecipitated 
was comparable to that before TGF- stimulation, even after TGF- stimulation for 30 
or 180 minutes (Fig. 3B). We also examined the effect of TGF- stimulation on the 
interaction of endogenous proteins. PC3 cells were treated with or without TGF-, then 
cell lysates were immunoprecipitated with anti-TRI antibody. Coimmunoprecipitated 
Dlg5 with TRI in TGF- treated cells was comparable to that in untreated cells (Fig. 
3C). These results suggest that TRI activation and kinase activity are not necessary 
for binding to Dlg5. 
 
3.3 Dlg5 colocalizes with TRs at the plasma membrane 
To test for colocalization of Dlg5 with the TRs in cells, Caco-2 colon epithelial 
cells were used. Caco-2 cells have well-organized cell-cell adhesion structures where 
Dlg5 localizes (data not shown). GFP-Dlg5ΔCC, TRI-Flag, and TRII-HA were 
cotransfected into Caco-2 cells. Cells were fixed and immunostained with anti-Flag 
and anti-HA antibodies. GFP-Dlg5ΔCC localized to the plasma membrane as well as 
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diffusely (Fig. 4), which is consistent with a previous report [3]. Both TRI-Flag and 
TRII-HA were also detected at the plasma membrane as well as in the cytosol (Fig. 4). 
The merged image indicates the colocalization of TRI, TRII, and GFP-Dlg5ΔCC at 
the plasma membrane. These results suggest that GFP-Dlg5ΔCC, TRI-Flag, and 
TRII-HA colocalize at the plasma membrane in Caco-2 cells. 
 
3.4 Dlg5 overexpression promotes TRI degradation 
The degradation of TRI and TRII is one of main regulatory mechanisms of 
TGF- signaling [18,22-25]. To investigate whether Dlg5 affects TRI degradation, 
GFP-Dlg5ΔCC and TRI-Flag were cotransfected into 293T cells. Twenty-four hours 
after transfection, cycloheximide was added to the culture medium to inhibit protein 
synthesis. After further incubation for 0-8 hours, TRI expression was examined by 
immunoblotting with anti-Flag antibody. As shown in Fig. 5A, TRI levels decreased 
only slightly over time in control cells. In contrast, TRI levels decreased significantly 
faster in Dlg5ΔCC-expressing cells. A quantitative analysis showed that the amount of 
TRI was reduced to 80 % and 50 % in control and Dlg5ΔCC-expressing cells, 
respectively, 4 hours after the addition of cycloheximide (Fig. 5B). Consistent with this 
overexpression experiments, Dlg5 knockdown in PC3 cells significantly increased the 
TRI expression both under TGF--stimulated and -unstimulated conditions (Fig. 5C, 
D). TRII degradation after cycloheximide treatment was also examined in 293T cells, 
but it was very slow and no decrease in TRII protein levels was detected, even eight 
hours after cycloheximide treatment (data not shown). These results suggest that Dlg5 
promotes the degradation of TRI. 
Proteasomal and lysosomal degradation pathways mediate TRI degradation, which 
is enhanced by its interaction with Smad7 [18,24]. To test which degradation pathway is 
engaged by Dlg5, cells were cotransfected with GFP-Dlg5ΔCC and TRI-Flag and then 
treated with the proteasome inhibitor MG132 or the lysosome inhibitor bafilomycin for 
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8 hours. Consistent with Fig. 5, Dlg5ΔCC overexpression significantly decreased TRI 
protein levels (Fig. 6A, D). Treatment with MG132 significantly increased TRI levels 
in Dlg5ΔCC-overexpressing cells but not in control cells (Fig. 6B, E). Quantitative 
analysis showed that MG132 treatment increased TRI levels 1.3-fold. Another 
proteasome inhibitor, ALLN, also increased TRI levels in GFP-Dlg5ΔCC expressing 
cells (data not shown). In contrast, bafilomycin increased TRI levels in both control 
and Dlg5ΔCC-overexpressing cells (Fig. 6C, F). These results suggest that Dlg5 
enhances the proteasome-dependent degradation of TRI. 
 
4. Discussion 
Dlg5, a member of the MAGUK family of adaptor proteins, localizes at cell-cell 
adhesion sites. We previously showed that Dlg5 suppresses TR-mediated signaling and 
EMT in renal epithelial cells [12]. However, the mechanism of this suppression is 
unknown. In this research, we found that both TRI-Flag and TRII-HA were clearly 
coprecipitated with Dlg5ΔCC. Furthermore, endogenous Dlg5 was also 
coimmunoprecipitated with endogenous TRI in PC3 cells. GFP-Dlg5 was colocalized 
with TRI-Flag and TRII-HA at cell-cell adhesion sites in Caco-2 cells. These results 
indicate that Dlg5 forms a signaling complex with TRs at the plasma membrane. 
We showed here that treatment with proteasome inhibitors suppressed 
Dlg5ΔCC-enhanced TRI degradation. Lysosome inhibitor increased the TRI 
expression in Dlg5ΔCC-expressing cells but it also increased the expression in control 
cells, implying that Dlg5 enhanced TRI degradation via proteasome-dependent 
mechanisms. In some cases, negative regulators of TGF- signaling associate with 
TRs and promote TR degradation via proteasome- and lysosome-dependent pathways 
simultaneously [18,24,25]. In other cases, only proteasomal degradation contributes to 




Expression of the TGF--signaling inhibitor Smad7 is enhanced by TGF- 
stimulation itself. The interaction of TRI with Smad7 is stimulated by TRI activation 
[18-20]. Thus, Smad7 seems to function in a negative feedback loop regulating TGF- 
signaling. In contrast, the interaction of Dlg5 with TRI was not stimulated by TRI 
activation. Both the constitutively active mutant of TRI (CA-TRI) and the 
kinase-dead mutant KD-TRI bind Dlg5 in a manner comparable to the wild type 
receptor. TGF- stimulation for 30 or 180 minutes did not affect these interactions. 
Furthermore, Dlg5 expression decreases after TGF- stimulation [12]. Thus, Dlg5 
seems to participate in positive feedback (specifically double-negative type feedback 
[27,28]) loop regulating TGF- signaling but not in a normal negative feedback loop. 
Alternatively, Dlg5 may suppress leaky (non-specific) activation of TGF- signaling by 
binding TRs, in a mechanism similar to FKBP12 [29]. 
The dysregulation of TGF- signaling increases the risk of CD. TGF-1 knockout 
mice develop systemic inflammation, including in the gut [30]. High levels of Smad7 
are observed in CD patients [31], and its knockdown attenuates experimental colitis in 
mice [32]. We found that Dlg5 interacts with TRs and promotes their degradation. 
These results may explain how Dlg5 polymorphisms affect the development of IBD, 
including CD. Future experiments will be directed towards understanding the 
relationship between Dlg5 polymorphisms and the regulation of TR signaling. 
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Figure 1. GFP-Dlg5 is coimmunoprecipitated with TRI-Flag and TRII-HA. A-C: 
GFP or GFP-Dlg5ΔCC were cotransfected into 293T cells together with Flag-tagged 
TRI and HA-tagged TRII (A), Flag-tagged TRI (B) or HA-tagged TRII (C). Cell 
lysates were subject to immunoprecipitation (IP) with an anti-GFP antibody. Immune 
complexes were examined using the antibodies indicated. Arrows mean differentially 
glycosylated forms of TRII. D: TRI-Flag, as well as either GFP, GFP-Dlg5, 
GFP-Dlg5 or GFP-Dlg5ΔCC, was transfected into 293T cells. Cell lysates were 
immunoprecipitated with anti-GFP antibody, and immunoblotting was performed with 
the antibodies indicated. E: Schematic diagram showing the protein domains of Dlg5, 
-, and -ΔCC. Dlg5 contains CARD, coiled-coil, SH3, and GUK domains, as well as 
four PDZ domains. Dlg5 and  are splice variants. Dlg5ΔCC is a deletion mutant that 
lacks the CARD and coiled-coil domains. 
 
Figure 2. Endogenous Dlg5 is coimmunoprecipitated with TRI in PC3 cells. PC3 
cells were transfected with Dlg5 siRNA and incubated for three days. The cells were 
then lysed and immunoprecipitated with anti-TRI antibody or control IgG. The 
immune complexes were examined with the antibodies indicated. 
 
Figure 3. TRI activation and kinase activity are not necessary for binding to Dlg5. 
A: GFP-Dlg5ΔCC, together with Flag-tagged wild type (WT), constitutively active 
(CA) or kinase-dead (KD) TRI, was transfected into 293T cells. Cell lysates were 
immunoprecipitated (IP) with anti-GFP antibody and immunoblotted with the antibodies 
indicated. The expression levels of KD-TRI were low for unknown reasons. B: 293T 
cells were transfected with Flag-tagged TRI and GFP-tagged Dlg5ΔCC. The cells were 
then treated with TGF- for 30 or 180 minutes, followed by immunoprecipitation and 
immunoblotting with the antibodies indicated. C: PC3 cells were treated with or without 





Figure 4. Dlg5 colocalizes with TRI and TRII. Caco-2 cells were cotransfected 
with TRI-Flag, TRII-HA and GFP-Dlg5ΔCC. The cells were fixed and 
immunostained with anti-Flag and anti-HA antibodies. Dlg5 was visualized by GFP 
fluorescence.  
 
Figure 5. Dlg5 promotes TRI degradation. A: GFP-Dlg5ΔCC and TRI-Flag were 
cotransfected into 293T cells. Twenty-four hours after transfection, 100 g/ml 
cycloheximide was added to the culture medium to inhibit protein synthesis. After 
further incubation for 0-8 hours, TRI expression was determined by immunoblotting 
with an anti-Flag antibody. B: The relative TRI expression in A was quantified. The 
values represent the mean ± S.E. from three independent experiments. C: PC3 cells 
were transfected with Dlg5 siRNA and incubated for three days. The cells were then 
treated with TGF- for 30 minutes, followed by immunoblotting with the indicated 
antibodies. Vinculin was used as a loading control. D: TRI expression in C was 
quantified. The values represent the mean ± S.E. from three independent experiments. 
 
Figure 6. Dlg5-enhanced TRI degradation involves proteasome. A-C: Cells were 
cotransfected with GFP-Dlg5ΔCC and TRI-Flag, then treated without (A) or with 
MG132 (B) or bafilomycin (C). After incubation for eight hours, TRI levels were 
determined by immunoblotting with the antibodies indicated. Vinculin was used as a 
loading control. D-F: TRI expression in A-C was quantified. The values represent the 
mean ± S.E. from three independent experiments. 
 
 
 
 
 






